Synthesis, characterization and crystal structure of the cis-[RhL2Cl2]Cl complex with the bifunctional ligand (L) 2-(2′-pyridyl)quinoxaline. Biological activity towards PAF (Platelet Activating Factor) induced platelet aggregation

The reaction of RhCl3·3H2O with the ligand L = 2-(2′-pyridyl)quinoxaline (pqo) in a 1:2 molar ratio formed the mononuclear complex cis-[RhL2Cl2]Cl (1), which has been characterized by elemental analysis, FT-IR, FT-Raman, 1H, 13C NMR, electronic absorption spectroscopy and by electrospray mass spectrometry. The molecular structure of 1 (needle like and prismatic polymorphs) in the crystal has been elucidated by single-crystal X-ray diffraction, revealing a bidentate behavior of L, while the geometry around the Rh(III) atom is that of a distorted octahedron.. Preliminary biological tests revealed that this compound inhibited PAF-induced rabbit platelet aggregation.

The mononuclear Rh(III) complex, cis-[RhL2Cl2]Cl (1) where L = 2-(2′-pyridyl) quinoxaline (pqo) has been prepared and fully characterized. The molecular structure in the crystal of complex 1 is also described, revealing a distorted octahedral geometry. The effect of this compound on PAF-induced rabbit platelet aggregation was investigated.Figure optionsDownload as PowerPoint slide